Ribeiro, Deidiane Elisa 
; Petiz, Lyvia Lintzmaier ; Glaser, Talita ; Giacomelli, Ágatha Oliveira ; Andrejew, Roberta ; Saab, Fernando de Azevedo Ribeiro; Milanis, Milena da Silva ; Campos, Henrique Correia; Sampaio, Vanessa Fernandes Arnaud ; La Banca, Sophia; Longo, Beatriz Monteiro ; Lameu, Claudiana ; Tang, Yong; Resende, Rodrigo Ribeiro ; Ferreira, Sergio T ; Ulrich, Henning
Source: Neuropharmacology. Unidade: IQ
Subjects: NEUROPSIQUIATRIA, DOENÇA DE ALZHEIMER, DEPRESSÃO, TRANSTORNOS DO SONO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Deidiane Elisa et al. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease. Neuropharmacology, v. 226, p. 1-16 art. 109371, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.neuropharm.2022.109371. Acesso em: 09 nov. 2024.APA
Ribeiro, D. E., Petiz, L. L., Glaser, T., Giacomelli, Á. O., Andrejew, R., Saab, F. de A. R., et al. (2023). Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease. Neuropharmacology, 226, 1-16 art. 109371. doi:10.1016/j.neuropharm.2022.109371NLM
Ribeiro DE, Petiz LL, Glaser T, Giacomelli ÁO, Andrejew R, Saab F de AR, Milanis M da S, Campos HC, Sampaio VFA, La Banca S, Longo BM, Lameu C, Tang Y, Resende RR, Ferreira ST, Ulrich H. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease [Internet]. Neuropharmacology. 2023 ; 226 1-16 art. 109371.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.neuropharm.2022.109371Vancouver
Ribeiro DE, Petiz LL, Glaser T, Giacomelli ÁO, Andrejew R, Saab F de AR, Milanis M da S, Campos HC, Sampaio VFA, La Banca S, Longo BM, Lameu C, Tang Y, Resende RR, Ferreira ST, Ulrich H. Purinergic signaling in cognitive impairment and neuropsychiatric symptoms of Alzheimer’s disease [Internet]. Neuropharmacology. 2023 ; 226 1-16 art. 109371.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.neuropharm.2022.109371
